Other in vitro and in vivo studies showed that high concentrations of OLE from Iran alone [25] or in combination with bevacizumab [28] significantly reduced the high vascular endothelial growth factor (VEGF) levels in a breast cancer model. Here, VEGFA is linked to breast carcinoma.